← Leaderboards
Lawrence R Smith
Vical, Inc.
$9,015,929
Attributed
$9,015,929
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.4M · FY2005–09$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$9,015,929 · 3
By mechanism
U01$5,613,677 · 1
UC1$2,902,252 · 1
R43$500,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Influenza A Virus, H5n1 Subtype”
- Richard Webby · St. Jude Children'S Research Hospital$26,471,114
- Yoshihiro Kawaoka · University Of Wisconsin Madison$22,241,007
- Robert Wilson Frenck · Cincinnati Childrens Hosp Med Ctr$19,142,225
- Michael Gale · University Of Washington$12,980,017
- Mark Joseph Mulligan · New York University School Of Medicine$11,718,364
- Robert M Krug · University Of Texas Austin$11,419,805
Research focus
Influenza A Virus, H5n1 SubtypeInfluenzaCessation Of LifeH5 HemagglutininBirdsHemagglutininDesignDesign And ConstructionBaseBiodistributionDisease OutbreaksComputersDoseConsumptionEngineering DesignEvaluationEventFerretsClinical ResearchFutureGenerationsGenesGenomicsInfluenza Hemagglutinin
Grant awards (5)
Pandemic influenza DNA vaccine Development$2,090,882
U01 · FY2009 · AI · contact PI
Pandemic influenza DNA vaccine Development$2,109,388
U01 · FY2008 · AI · contact PI
Pandemic influenza DNA vaccine Development$1,413,407
U01 · FY2007 · AI · contact PI
Biodefense vaccine for pandemic influenza$2,902,252
UC1 · FY2005 · AI
Development of a DNA Vaccine Against Influenza Virus$500,000
R43 · FY2005 · AI